Celgene abandons Crohn's disease drug trials
October 19, 2017 at 16:44 PM EDT
Oct 19 (Reuters) - Celgene Corp said on Thursday it would stop two studies of its drug for an inflammatory bowel disease and would not begin a third, following a recommendation by a data monitoring committee.
